Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the molecular mechanisms of a novel group of small-molecule Bax inhibitors
FY 2021-22
Summary
The mitochondria has always been known as the ;powerhouse of the cell. However, the association between neuronal health and mitochondrial function is something that is not widely known. When a neuronal cell encounters a stressor during a stroke (oxygen deprivation), brain injury (physical trauma) or epileptic seizure (electrical disturbance), a pore forms on the mitochondria which ultimately results in a signal cascade that leads to cell death. Therefore, the prognosis of patients is largely influenced by the magnitude of neuronal cell death following one of the aforementioned events.The David Andrews lab specializes in uncovering how a protein called Bax regulates mitochondrial dynamics during cell death. Recently, we uncovered several small molecules that inhibit Bax activation. Therefore for this proposal, we seek to understand the mechanism by which the small molecules suppress Bax-mediated cell death. First, we wish to characterize the binding site and affinity of the small molecule inhibitors to Bax. Second, we would like to uncover whether Bax activation is suppressed by the small molecules on the mitochondria or elsewhere in the cell. Third, we wish to study Bax dynamics and behaviour once it is suppressed by the small molecule inhibitors. Finally, we need to assess and quantify the extent to which the small molecule inhibitors prevent Bax-mediated cell death.Understanding how the small molecule inhibitors suppress Bax activation from a mechanistic point of view is predicted to facilitate future drug design aimed at ameliorating patient prognosis following a stroke, seizure, or brain injury. Thus, Bax is a promising druggable target with medicinal potential.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466493
Name
Aljghami Mazen E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the molecular mechanisms of a novel group of small-molecule Bax inhibitors
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoptosis Prevention; Bcl-2 Protein Dynamics; Drug Development; Drug-Protein Interactions; Mitochondrial Dynamics; Molecular Mechanisms; Prevention Of Neuronal Degeneration (E.G.In Stroke; Protein-Protein Interactions; Reducing Chemotherapy Cytotoxic Side Effects; Seizure)
Abstract
The mitochondria has always been known as the ;powerhouse of the cell. However, the association between neuronal health and mitochondrial function is something that is not widely known. When a neuronal cell encounters a stressor during a stroke (oxygen deprivation), brain injury (physical trauma) or epileptic seizure (electrical disturbance), a pore forms on the mitochondria which ultimately results in a signal cascade that leads to cell death. Therefore, the prognosis of patients is largely influenced by the magnitude of neuronal cell death following one of the aforementioned events.The David Andrews lab specializes in uncovering how a protein called Bax regulates mitochondrial dynamics during cell death. Recently, we uncovered several small molecules that inhibit Bax activation. Therefore for this proposal, we seek to understand the mechanism by which the small molecules suppress Bax-mediated cell death. First, we wish to characterize the binding site and affinity of the small molecule inhibitors to Bax. Second, we would like to uncover whether Bax activation is suppressed by the small molecules on the mitochondria or elsewhere in the cell. Third, we wish to study Bax dynamics and behaviour once it is suppressed by the small molecule inhibitors. Finally, we need to assess and quantify the extent to which the small molecule inhibitors prevent Bax-mediated cell death.Understanding how the small molecule inhibitors suppress Bax activation from a mechanistic point of view is predicted to facilitate future drug design aimed at ameliorating patient prognosis following a stroke, seizure, or brain injury. Thus, Bax is a promising druggable target with medicinal potential.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Aljghami, Mazen E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~